Ellevest, Inc. Repligen Corp Transaction History

Ellevest, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$154.26 - $198.1 $11,723 - $15,055	-76 Reduced 34.86%	142 $23,000
Q4 2022 Feb 03, 2023	SELL	$162.42 - $220.56 $20,789 - $28,231	-128 Reduced 36.99%	218 $36,000
Q3 2022 Nov 02, 2022	BUY	$160.42 - $256.21 $46,361 - $74,044	289 Added 507.02%	346 $65,000
Q2 2022 Jul 18, 2022	BUY	$140.68 - $188.02 $422 - $564	3 Added 5.56%	57 $9,000
Q1 2022 Apr 19, 2022	BUY	$161.19 - $257.96 $6,769 - $10,834	42 Added 350.0%	54 $10,000
Q4 2021 Jan 24, 2022	BUY	$247.59 - $304.47 $495 - $608	2 Added 20.0%	12 $3,000
Q3 2021 Oct 19, 2021	BUY	$194.77 - $324.21 $1,947 - $3,242	10 New	10 $3,000
Q2 2021 Jul 13, 2021	SELL	$165.87 - $220.95 $3,815 - $5,081	-23 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$180.37 - $226.26 $2,344 - $2,941	13 Added 130.0%	23 $4,000
Q4 2020 Feb 04, 2021	BUY	$148.08 - $206.57 $1,480 - $2,065	10 New	10 $2,000

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.